Buy BIIB Call

We like the action in Biogen (BIIB) and have played it in the past. Both times making money, 67% and 29%.

The Erlanger Short Intensity is high at 74% and the Technical Rank is neutral at 50%. Improvement takes it to a Short Squeeze.

We will buy the BIIB October 16th $230 Call for $5.15 which is the midpoint of the current bid/ask.

BIIB Is trading at $213.41